Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Madison Blue's research investigates the metabolic pathways involved in the bioactivation and detoxification of non-steroidal anti-inflammatory drugs (NSAIDs) derived from diphenylamine. Their work specifically examines the roles of Cytochrome P450 enzymes, including CYP2C9 and CYP3A4, in these processes. Blue's recent publication explored how these enzymes interact to influence the drug metabolism of diphenylamine NSAIDs. This research contributes to understanding drug metabolism and potential toxicity.
Metrics
- h-index: 1
- Publications: 1
- Citations: 7
Selected Publications
-
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs (2021)
Collaboration Network
Top Collaborators
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs
Similar Researchers
Based on overlapping research topics